- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
The Administration Strategic Preparedness and Response (ASPR) announced two new investments in domestic production of active pharmaceutical ingredients (API) in the United States under the Defense Production Act Monday (Nov. 25), which it says will aim to rebuild and protect the U.S. public health supply chain as an essential part of national defense.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us